News of Note—Bavarian Nordic, vaccine hesitancy and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> The U.S. government signed off on a $44 million option in its smallpox vaccine contract with Bavarian Nordic. Release

> WHO has named vaccine hesitancy and Ebola among its top 10 threats to global health in 2019. ABC News article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> An Alzheimer's disease vaccine from United Neuroscience performed favorably in a phase 2 study, the biotech said. Bloomberg Businessweek article

> Valneva secured a $59 million contract with the U.S. Department of Defense to supply its Japanese encephalitis vaccine Ixiaro. Release

> CDMO Almac is expanding its capacity to manufacture personalized cancer vaccines. Outsourcing-Pharma article

Suggested Articles

An FDA panel gave Sanofi's Dengvaxia a mixed endorsement, voting down its use in people 17 and older.

Prosecutors in the Philippines have found probable cause to indict six Sanofi officials for its Dengvaxia rollout.

The FDA has issued guidance on continuous manufacturing and is allocating $58 million to move forward advanced manufacturing processes.